Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 12.11.2024
Fate Therapeutics Мультипликаторы 2011-2024 | FATE
Мультипликаторы по годам Fate Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.2 | -2.1 | -26.1 | -43.2 | -18.0 | -12.5 | -9.1 | -2.6 | -1.8 | -4.0 | -1.8 | - | - |
P/S |
10.7 | 6.2 | 99.3 | 238.3 | 165.1 | 175.0 | 95.7 | 20.1 | 22.5 | - | 38.0 | - | - |
EPS |
-1.6 | -2.9 | -2.2 | -2.1 | -1.4 | -1.2 | -1.0 | -1.1 | -1.2 | -1.3 | -3.5 | -13.1 | -16.2 |
EV (Enterprise Value) |
637 млн | 533 млн | 5.41 млрд | 7.32 млрд | 1.72 млрд | 691 млн | 332 млн | 21.6 млн | 19.9 млн | 78.1 млн | -12.4 млн | 54.8 млн | 52.1 млн |
EBITDA per Share |
-1.75 | -3.04 | -2.23 | -1.52 | -1.44 | -1.17 | -0.98 | -0.979 | -1.06 | -1.19 | -2.9 | - | - |
EV/EBITDA |
-25.4 | -62.0 | -16.9 | -9.9 | -7.7 | -0.3 | -0.3 | -3.1 | 0.9 | - | - | ||
PEG |
-0.31 | -0.08 | -1.38 | -5.37 | 0.86 | 0.75 | -3.2 | -0.24 | -0.26 | -0.06 | 0.02 | - | - |
P/B |
1.3 | 0.8 | 6.0 | 12.0 | 7.2 | 5.2 | 5.1 | 1.2 | 1.4 | 3.7 | 0.7 | - | - |
P/CF |
-5.1 | -2.4 | -34.0 | -191.0 | -19.5 | -20.3 | -10.2 | -2.9 | -2.8 | -4.5 | -2.4 | - | - |
ROE % |
-43.68 | -58.21 | -31.25 | -45.10 | -40.10 | -41.50 | -55.65 | -45.74 | -78.85 | -91.33 | -41.09 | - | - |
ROA % |
-31.79 | -39.93 | -23.02 | -27.86 | -32.47 | -31.26 | -40.79 | -35.21 | -44.13 | -50.55 | -37.59 | - | - |
ROCE % |
-51.71 | -63.72 | -31.97 | -33.32 | -36.70 | -36.12 | -44.70 | -40.02 | -50.96 | -53.42 | -34.67 | - | - |
Current Ratio |
- | - | - | - | 8.2 | 7.5 | 9.3 | 6.1 | 4.9 | 10.9 | 11.9 | - | - |
DSO |
115.8 | 89.4 | 46.4 | 32.0 | - | 38.5 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
115.8 | 89.4 | 46.4 | 32.0 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
115.8 | 89.4 | 46.4 | 32.0 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Fate Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.4 | -0.33 | - | -0.46 | -0.54 | -0.19 | - | -0.86 | -0.79 | -0.68 | - | -0.45 | -0.58 | -0.48 | - | -0.68 | -0.35 | -0.44 | -0.37 | -0.4 | -0.36 | -0.3 | -0.25 | -0.31 | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 | -0.24 | -0.21 | -0.27 | -0.29 | -0.29 | -0.26 | -0.24 | -0.33 | -0.38 | -0.3 | -0.32 | -0.3 | -0.34 | -0.29 | -4.81 | -4.46 | -2.92 | -3.51 | -3.51 | -2.58 | -3.43 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | -0.25 | - | -0.8 | -0.86 | -0.74 | - | -0.53 | -0.5 | -0.48 | - | -0.34 | -0.34 | -0.45 | - | -0.38 | -0.35 | -0.31 | - | -0.29 | -0.36 | -0.26 | - | -0.23 | -0.22 | -0.24 | - | -0.24 | -0.26 | -0.27 | - | -0.2 | -0.29 | -0.35 | - | -0.27 | -0.28 | -0.33 | - | -3.73 | -3.2 | -2.64 | - | -2.75 | - | - | - | - | - | - |
ROE % |
-45.27 | -44.16 | -27.22 | -43.35 | -48.27 | -49.33 | -39.61 | -45.54 | -35.34 | -29.56 | -18.97 | -34.23 | -43.57 | -43.54 | -31.29 | -42.85 | -38.46 | -40.75 | -40.10 | -38.52 | -38.11 | -40.77 | -41.50 | -47.70 | -51.09 | -51.34 | -55.65 | -50.31 | -48.41 | -47.41 | -45.74 | -54.46 | -60.62 | -69.58 | -78.85 | -81.27 | -86.46 | -87.42 | -91.33 | -80.62 | -69.27 | -58.74 | -41.09 | -21.94 | -2.21 | 8.67 | 15.65 | 7.79 | - | - | - | - | - | - |
ROA % |
-33.51 | -32.90 | -20.32 | -31.48 | -34.32 | -32.95 | -26.46 | -30.86 | -16.45 | -21.88 | -14.14 | -23.57 | -28.59 | -27.68 | -19.32 | -28.69 | -28.06 | -31.32 | -32.47 | -30.63 | -29.71 | -31.16 | -31.26 | -35.61 | -37.88 | -37.81 | -40.79 | -37.28 | -36.32 | -36.01 | -35.21 | -37.81 | -38.75 | -41.35 | -44.13 | -45.35 | -48.12 | -48.53 | -50.56 | -48.71 | -46.74 | -44.84 | -37.59 | -64.78 | -90.99 | -81.03 | -74.65 | -37.13 | - | - | - | - | - | - |
ROCE % |
-51.27 | -51.11 | -33.01 | -49.69 | -53.64 | -53.66 | -42.75 | -50.23 | -41.03 | -32.94 | -19.55 | -27.74 | -28.45 | -29.70 | -24.63 | -35.71 | -38.60 | -40.97 | -29.27 | -39.68 | -39.00 | -41.37 | -31.38 | -44.77 | -47.77 | -47.95 | -38.71 | -50.18 | -48.25 | -46.79 | -33.23 | -49.87 | -55.03 | -63.07 | -54.87 | -75.98 | -80.46 | -82.80 | -66.91 | -77.03 | -66.04 | -53.12 | -25.12 | -18.21 | -1.18 | 7.22 | 6.91 | 6.91 | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
76.8 | 19.4 | - | 102.6 | 798.7 | 40.2 | - | 31.1 | 34.1 | 55.8 | - | 56.5 | 58.7 | 51.0 | - | 66.6 | 92.1 | 100.0 | - | - | 8.1 | 17.3 | 27.5 | 44.5 | 44.4 | 22.2 | - | - | - | - | - | - | - | - | 35.9 | 37.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
76.8 | 19.4 | - | 102.6 | 798.7 | 40.2 | - | 31.1 | 34.1 | 55.8 | - | 56.5 | 58.7 | 51.0 | - | 66.6 | 92.1 | 100.0 | - | - | 8.1 | 17.3 | 27.5 | 44.5 | 44.4 | 22.2 | - | - | - | - | - | - | - | - | 35.9 | 37.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
76.8 | 19.4 | - | 102.6 | 798.7 | 40.2 | - | 31.1 | 34.1 | 55.8 | - | 56.5 | 58.7 | 51.0 | - | 66.6 | 92.1 | 100.0 | - | - | 8.1 | 17.3 | 27.5 | 44.5 | 44.4 | 22.2 | - | - | - | - | - | - | - | - | 35.9 | 37.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD